Ubs Group Ag Prime Medicine, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 35,021 shares of PRME stock, worth $117,320. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,021

Previous 22,539 55.38%

Holding current value

$117,320

Previous $115,000 17.39%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.41 - $6.7 $42,563 - $83,629	12,482 Added 55.38%	35,021 $135,000
Q2 2024 Aug 13, 2024	SELL	$4.3 - $8.03 $85,931 - $160,471	-19,984 Reduced 47.0%	22,539 $115,000
Q1 2024 May 13, 2024	BUY	$6.35 - $9.39 $70,554 - $104,332	11,111 Added 35.37%	42,523 $297,000
Q4 2023 Feb 09, 2024	SELL	$5.59 - $9.55 $69,092 - $118,038	-12,360 Reduced 28.24%	31,412 $278,000
Q3 2023 Nov 09, 2023	SELL	$9.5 - $15.07 $525,036 - $832,873	-55,267 Reduced 55.8%	43,772 $417,000
Q2 2023 Aug 11, 2023	BUY	$11.41 - $17.05 $1.07 Million - $1.6 Million	94,104 Added 1906.87%	99,039 $1.45 Million
Q1 2023 May 12, 2023	BUY	$11.21 - $21.11 $41,768 - $78,655	3,726 Added 308.19%	4,935 $60,000
Q4 2022 Feb 08, 2023	BUY	$15.2 - $21.12 $18,376 - $25,534	1,209 New	1,209 $22,000

Others Institutions Holding PRME

# of Institutions

124

Shares Held

64.7M

Call Options Held

324K

Put Options Held

64.4K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $321M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account